Global Cross-Company Audit Initiative Launched
We are delighted to announce the launch of our global cross-company audit initiative, a key step toward harmonizing practices across the KD Pharma Group. This initiative fosters continuous improvement and knowledge sharing, ensuring alignment across all regions. The first audit, conducted collaboratively by teams from KD Bexbach GmbH and KD Norway AS, brought together a wealth of knowledge and a deep understanding of various regulatory requirements.
A special thank you to our colleagues in Piura for their warm welcome and support. Your dedication strengthens our commitment to excellence. This initiative brings tangible value to our customers, ensuring:
• Enhanced Quality & Consistency: Standardized practices ensure top-tier service and products worldwide.
• Innovative Solutions: Diverse expertise drives continuous improvement and innovation.
• Trust & Reliability: Rigorous audits reinforce our commitment to excellence and compliance.
Together, we continue to learn, grow, and set new standards of excellence!
